Pheast Therapeutics

Pheast is a pre-clinical stage immuno-oncology company focused on targeting cancer immune evasion pathways to activate the innate immune system in the fight against cancer. 

Parachute
Biotech

New year, new C-suite execs—Chutes & Ladders

The biopharma world rang in the new year with new faces and C-suite exits at Moderna, Biogen, Galapagos, Zymeworks and more
Gabrielle Masson , Max Bayer Jan 6, 2023 9:30am
graphic of a man with money identifying new ideas

Arch raises nearly $3B amid cratering biotech market

Jun 29, 2022 11:15am
Role of hundred dollar bills on other bills

Catalio reloads with $381M after financing Octant, Pheast

May 4, 2022 9:21am